These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 37166538)
1. Research progress on the pathogenesis of CDKL5 pathogenic variants and related encephalopathy. Sun X; Wang T Eur J Pediatr; 2023 Jul; 182(7):3049-3056. PubMed ID: 37166538 [TBL] [Abstract][Full Text] [Related]
3. What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy. Kilstrup-Nielsen C; Rusconi L; La Montanara P; Ciceri D; Bergo A; Bedogni F; Landsberger N Neural Plast; 2012; 2012():728267. PubMed ID: 22779007 [TBL] [Abstract][Full Text] [Related]
4. Molecular and Synaptic Bases of CDKL5 Disorder. Zhu YC; Xiong ZQ Dev Neurobiol; 2019 Jan; 79(1):8-19. PubMed ID: 30246934 [TBL] [Abstract][Full Text] [Related]
5. Novel CDKL5 targets identified in human iPSC-derived neurons. Massey S; Ang CS; Davidson NM; Quigley A; Rollo B; Harris AR; Kapsa RMI; Christodoulou J; Van Bergen NJ Cell Mol Life Sci; 2024 Aug; 81(1):347. PubMed ID: 39136782 [TBL] [Abstract][Full Text] [Related]
6. Novel mutations in cyclin-dependent kinase-like 5 (CDKL5) gene in Indian cases of Rett syndrome. Das DK; Mehta B; Menon SR; Raha S; Udani V Neuromolecular Med; 2013 Mar; 15(1):218-25. PubMed ID: 23242510 [TBL] [Abstract][Full Text] [Related]
7. Two Novel Variants Affecting CDKL5 Transcript Associated with Epileptic Encephalopathy. Neupauerová J; Štěrbová K; Vlčková M; Sebroňová V; Maříková T; Krůtová M; David S; Kršek P; Žaliová M; Seeman P; Laššuthová P Genet Test Mol Biomarkers; 2017 Oct; 21(10):613-618. PubMed ID: 28872899 [TBL] [Abstract][Full Text] [Related]
8. Clinical features and gene mutational spectrum of CDKL5-related diseases in a cohort of Chinese patients. Zhao Y; Zhang X; Bao X; Zhang Q; Zhang J; Cao G; Zhang J; Li J; Wei L; Pan H; Wu X BMC Med Genet; 2014 Feb; 15():24. PubMed ID: 24564546 [TBL] [Abstract][Full Text] [Related]
9. CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling. Fuchs C; Medici G; Trazzi S; Gennaccaro L; Galvani G; Berteotti C; Ren E; Loi M; Ciani E Brain Pathol; 2019 Sep; 29(5):658-674. PubMed ID: 30793413 [TBL] [Abstract][Full Text] [Related]
10. Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder. Katayama S; Sueyoshi N; Inazu T; Kameshita I Neural Plast; 2020; 2020():6970190. PubMed ID: 32587608 [TBL] [Abstract][Full Text] [Related]
11. Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. Muñoz IM; Morgan ME; Peltier J; Weiland F; Gregorczyk M; Brown FC; Macartney T; Toth R; Trost M; Rouse J EMBO J; 2018 Dec; 37(24):. PubMed ID: 30266825 [TBL] [Abstract][Full Text] [Related]
12. Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder. Voronin G; Narasimhan J; Gittens J; Sheedy J; Lipari P; Peters M; DeMarco S; Cao L; Varganov Y; Kim MJ; Pear L; Fotouh E; Sinha S; Ray B; Wu MC; Yalamanchili P; Southgate C; Pick J; Saadipour K; Jung S; Lee J; Mollin A; Welch EM; Wu Z; Weetall M Mol Ther; 2024 Oct; 32(10):3331-3345. PubMed ID: 39033321 [TBL] [Abstract][Full Text] [Related]
13. CDKL5 deficiency disorder in males: Five new variants and review of the literature. Siri B; Varesio C; Freri E; Darra F; Gana S; Mei D; Porta F; Fontana E; Galati G; Solazzi R; Niceta M; Veggiotti P; Alfei E Eur J Paediatr Neurol; 2021 Jul; 33():9-20. PubMed ID: 33989939 [TBL] [Abstract][Full Text] [Related]
14. Key clinical features to identify girls with CDKL5 mutations. Bahi-Buisson N; Nectoux J; Rosas-Vargas H; Milh M; Boddaert N; Girard B; Cances C; Ville D; Afenjar A; Rio M; Héron D; N'guyen Morel MA; Arzimanoglou A; Philippe C; Jonveaux P; Chelly J; Bienvenu T Brain; 2008 Oct; 131(Pt 10):2647-61. PubMed ID: 18790821 [TBL] [Abstract][Full Text] [Related]
16. The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo. Trovò L; Fuchs C; De Rosa R; Barbiero I; Tramarin M; Ciani E; Rusconi L; Kilstrup-Nielsen C Neurobiol Dis; 2020 May; 138():104791. PubMed ID: 32032735 [TBL] [Abstract][Full Text] [Related]
17. A GABA Gennaccaro L; Fuchs C; Loi M; Roncacè V; Trazzi S; Ait-Bali Y; Galvani G; Berardi AC; Medici G; Tassinari M; Ren E; Rimondini R; Giustetto M; Aicardi G; Ciani E Neurobiol Dis; 2021 Jun; 153():105304. PubMed ID: 33621640 [TBL] [Abstract][Full Text] [Related]
18. Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy. Rosas-Vargas H; Bahi-Buisson N; Philippe C; Nectoux J; Girard B; N'Guyen Morel MA; Gitiaux C; Lazaro L; Odent S; Jonveaux P; Chelly J; Bienvenu T J Med Genet; 2008 Mar; 45(3):172-8. PubMed ID: 17993579 [TBL] [Abstract][Full Text] [Related]
19. Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons. Loi M; Trazzi S; Fuchs C; Galvani G; Medici G; Gennaccaro L; Tassinari M; Ciani E Mol Neurobiol; 2020 May; 57(5):2244-2262. PubMed ID: 32002787 [TBL] [Abstract][Full Text] [Related]
20. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset. MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]